Evidence from a New York City hospital of rising incidence of genetically diverse carbapenem-resistant Enterobacter cloacae and dominance of ST171, 2007-14

J Antimicrob Chemother. 2016 Aug;71(8):2351-3. doi: 10.1093/jac/dkw132. Epub 2016 Apr 26.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Carbapenem-Resistant Enterobacteriaceae / genetics*
  • Carbapenem-Resistant Enterobacteriaceae / isolation & purification
  • Carbapenems / pharmacology
  • Drug Resistance, Bacterial / genetics*
  • Enterobacter cloacae / drug effects
  • Enterobacter cloacae / genetics*
  • Enterobacter cloacae / isolation & purification
  • Enterobacteriaceae Infections / epidemiology*
  • Enterobacteriaceae Infections / microbiology
  • Genetic Variation*
  • Hospitals, Urban / statistics & numerical data
  • Humans
  • Incidence
  • New York City / epidemiology
  • Retrospective Studies
  • beta-Lactamases / biosynthesis
  • beta-Lactamases / genetics

Substances

  • Anti-Bacterial Agents
  • Carbapenems
  • beta-Lactamases